Health Economic Perspectives and the Future of Cancer Health

Dr. Christopher Longo discusses economic evaluations of cancer treatments -- recent trends, and future considerations.

Details

Date & Time

October 4, 2018
12:00 p.m. - 1:30 p.m.

Location

Burlington

Cost

$10

Students free with ID. Parking included. Transferable. Flex packages available.

Contact

An Kuye
kuyea@mcmaster.ca

Description

Presented by the Health Leadership Academy.

Dr. Christopher Longo will provide a brief background of how and why economic evaluations are completed. He will discuss recent trends, including guidance changes, and help you understand how these changes might affect how (and which) cancer drugs are funded. He will also discuss future considerations and changes which may be needed.

Dr. Longo has over 25 years of experience in clinical research, economic evaluation and access strategies for pharmaceuticals. His current research examines the costs and economic evaluation of interventions / programs throughout the cancer journey, with the intent of informing policy decision-making.

More information available on the HLA website.

Map

Burlington

(Ron Joyce Centre | DeGroote School of Business, South Service Road, Burlington, ON, Canada)

Leave a Reply

Your email address will not be published. Required fields are marked *

More Events

Influence and Leadership Presence


Burlington

High Impact Strategic Planning


Burlington

See the Calendar

Comment Policy

We generally welcome discussion on our blog posts. However, we reserve the right to edit or delete comments in certain situations:

  • Comments which include unrelated or suspicious links or messages (spam).
  • Comments which are off topic.
  • Comments which attack or threaten individuals or a group of people.
  • Comments which include profanity or messages that would generally be considered offensive or inappropriate by the McMaster community.

This site is moderated by the DeGroote Marketing and Community Engagement team. If you have any questions please email Jared Lenover.